Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Smith

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.
European Journal of Immunology|March 2, 2005
Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinasesMatthew J Thomas, Alexandra Smith, Denise H Head, et al.
Haematologica|January 29, 2026
Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based studyEve Roman, Timothy Bagguley, Simon Crouch, et al.
Military Medicine|March 4, 2026
Challenges with Tracking Post Concussive Symptoms Using the Neurobehavioral Symptom Inventory in Active Duty Service Members with Mild Traumatic Brain InjuryAmy O Bowles, Lisa A Brenner, Rachel Sayko Adams, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
European Journal of Pediatrics|June 18, 2021
Sleep behavior of infants with infantile hemangioma treated with propranolol-a cohort studyMartin Theiler, Nicole Knöpfel, Susanne von der Heydt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2015
Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in MiceJie Hong Hu, Hao Wei, Mia Jaffe, et al.
Iscience|October 28, 2022
Increased <i>KIF11</i>/<i>kinesin-5</i> expression offsets Alzheimer Aβ-mediated toxicity and cognitive dysfunctionEsteban M Lucero, Ronald K Freund, Alexandra Smith, et al.
Nature Genetics|September 19, 2023
Author Correction: Multiparameter prediction of myeloid neoplasia riskMuxin Gu, Sruthi Cheloor Kovilakam, William G Dunn, et al.
Nature Genetics|August 24, 2023
Multiparameter prediction of myeloid neoplasia riskMuxin Gu, Sruthi Cheloor Kovilakam, William G Dunn, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.
European Journal of Immunology|March 2, 2005
Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinasesMatthew J Thomas, Alexandra Smith, Denise H Head, et al.
Haematologica|January 29, 2026
Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based studyEve Roman, Timothy Bagguley, Simon Crouch, et al.
Military Medicine|March 4, 2026
Challenges with Tracking Post Concussive Symptoms Using the Neurobehavioral Symptom Inventory in Active Duty Service Members with Mild Traumatic Brain InjuryAmy O Bowles, Lisa A Brenner, Rachel Sayko Adams, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
European Journal of Pediatrics|June 18, 2021
Sleep behavior of infants with infantile hemangioma treated with propranolol-a cohort studyMartin Theiler, Nicole Knöpfel, Susanne von der Heydt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2015
Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in MiceJie Hong Hu, Hao Wei, Mia Jaffe, et al.
Iscience|October 28, 2022
Increased <i>KIF11</i>/<i>kinesin-5</i> expression offsets Alzheimer Aβ-mediated toxicity and cognitive dysfunctionEsteban M Lucero, Ronald K Freund, Alexandra Smith, et al.
Nature Genetics|September 19, 2023
Author Correction: Multiparameter prediction of myeloid neoplasia riskMuxin Gu, Sruthi Cheloor Kovilakam, William G Dunn, et al.
Nature Genetics|August 24, 2023
Multiparameter prediction of myeloid neoplasia riskMuxin Gu, Sruthi Cheloor Kovilakam, William G Dunn, et al.
Pageof 13